Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net (loss) income	$ (3,765)	$ (11,497)	$ 17,097
Less: Income from discontinued operations	0	0	(19,992)
Loss from continuing operations	(3,765)	(11,497)	(2,895)
Adjustments to reconcile loss from continuing operations to net cash provided by (used in) operating activities:
Net restructuring, severance and other charges	(333)	134	(349)
Net legal settlements	185	(1,511)	(110)
Asset impairments and related charges	87	3,454	327
Gain (Loss) on Disposition of Assets	381	0	0
Depreciation	2,199	2,225	2,074
Amortization	2,265	4,755	6,726
Share-based compensation	3,405	3,140	2,119
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	93	(1,619)	0
Deferred income taxes	23	(371)	(178)
Change in cash surrender value of company owned life insurance policies	(564)	(57)	(600)
Excess tax benefit from equity awards	0	(14)	(37)
Changes in operating assets and liabilities:
Accounts receivable	3,237	(1,935)	(7,846)
Inventories	(2,051)	(171)	380
Prepaid expense	(4,532)	(526)	(498)
Accounts payable	(7,896)	5,528	1,073
Deferred revenue	9,364	1,146	2,784
Accrued liabilities	5,330	(3,868)	1,624
Income taxes receivable	16	(823)	(2,702)
Other changes, net	(226)	(176)	(508)
Net cash provided by (used in) operating activities from continuing operations	7,218	(2,186)	1,384
Net cash used in operating activities from discontinued operations	0	0	1,311
Net cash provided by (used in) operating activities	7,218	(2,186)	73
Proceeds from sale of business units	0	809	35,846
Cash paid for acquisitions, net	0	(3,750)	(1,812)
Payments to Acquire Marketable Securities	0	(10,240)	0
Proceeds from sale of marketable securities	0	10,107	0
Capital expenditures	(4,845)	(4,650)	(4,023)
Capitalized software development costs	(16,103)	(15,813)	(12,200)
Additional (investments in) proceeds from corporate-owned life insurance policies	(65)	1,905	(87)
Net cash (used in) provided by investing activities from continuing operations	(21,013)	(21,632)	17,724
Net cash used in investing activities from discontinued operations	0	0	(155)
Net cash (used in) provided by investing activities	(21,013)	(21,632)	17,569
Financing activities
Principal payments under long-term obligations	(142)	(144)	(177)
Exercise of employee stock options	0	102	169
Repurchase of common shares to satisfy employee tax withholding	(435)	(373)	(912)
Excess tax benefit from equity awards	0	14	37
Net cash used in financing activities from continuing operations	(577)	(401)	(883)
Net cash used in financing activities from discontinued operations	0	0	(80)
Net cash used in financing activities	(577)	(401)	(963)
Effect of exchange rate changes on cash	(87)	(280)	(44)
Cash flows (used in) provided by continuing operations	(14,459)	(24,499)	18,181
Cash flows used in discontinued operations	0	0	(1,546)
Net (decrease) increase in cash and cash equivalents	(14,459)	(24,499)	16,635
Cash and cash equivalents at beginning of period	75,067	99,566	82,931
Cash and cash equivalents at end of period	$ 60,608	$ 75,067	$ 99,566